Safety, Pharmacokinetics, And Preliminary Efficacy Of Rycal S 48168 (Arm210) For Ryr1-Related Myopathies: A Phase One, Open-Label Doseescalation Trial

NEUROMUSCULAR DISORDERS(2021)

引用 0|浏览12
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要